Jose Nieto, MD
Nephrology · Miami, FLNPI 1811950132
Payments from drug & device makers
Across 194 payments — averaging $336.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$60K
- Ironwood Pharmaceuticals, Inc$1K
- Mallinckrodt Hospital Products Inc.$628
- AstraZeneca$577
- Amgen$421
- Vifor Pharma, Inc.$375
- plus $2K from 19 others
What the payments were for
- Food & beverage$3,87398%
- Education$732%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 21 | $60,289 |
| Ironwood Pharmaceuticals, Inc | 1 | $1,000 |
| Mallinckrodt Hospital Products Inc. | 28 | $628 |
| AstraZeneca | 29 | $577 |
| Amgen(2 entities) | 21 | $421 |
| Vifor Pharma, Inc. | 17 | $375 |
| Bayer | 13 | $344 |
| Aurinia Pharma U.S., Inc. | 11 | $236 |
| Novartis | 9 | $218 |
| Fresenius USA Marketing, Inc. | 9 | $185 |
| Calliditas Therapeutics US Inc. | 6 | $135 |
| Pentax Of America, Inc. | 1 | $129 |
| ANI Pharmaceuticals, Inc. | 4 | $126 |
| Travere Therapeutics, Inc. | 4 | $89 |
| Novo Nordisk | 4 | $75 |
| Mallinckrodt Enterprises LLC | 2 | $61 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $61 |
| OPKO Pharmaceuticals, LLC | 3 | $61 |
| Olympus America Inc. | 1 | $49 |
| Boehringer Ingelheim | 2 | $41 |
| Ardelyx, Inc. | 2 | $32 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $25 |
| Shire North American Group Inc | 1 | $21 |
| Otsuka America Pharmaceutical, Inc. | 1 | $19 |
| Pinnacle Biologics, Inc | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- C2 Cryoballoon$129
How this compares
$65,206 in reported general payments places this provider in the 85th percentile of 756 nephrology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Sevelamer Carbonate | 14 | $953 |
| Nifedipine ErNifedipine | 49 | $943 |
| Calcium Acetate | 20 | $681 |
| Lactulose | 11 | $407 |
| Furosemide | 39 | $196 |
| Clonidine Hcl | 12 | $172 |
| Losartan Potassium | 15 | $144 |
| Allopurinol | 17 | $136 |
| Ciprofloxacin Hcl | 15 | $130 |
| Lisinopril | 20 | $118 |
| Amlodipine Besylate | 18 | $24 |
Paid to pharmacies, not to this prescriber.
Other nephrology in Miami
- Oscar GalvezMiami$14.2M
- Juan FernandezMiami$2.5M
- Alessia FornoniMiami$2.1M
- Hassan AliMiami$1.4M
- Shadi TaraziMiami$739K
- Fernando TrespalaciosMiami$626K
- Manuel Garcia-EstradaMiami$476K
- Anne Marie MilesMiami$419K
- Gabriel ContrerasMiami$266K
- Jose Cardona-GuzmanMiami$245K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.